Z
002332
vs
ROG
Z
002332
ROG
Over the past 12 months, Zhejiang Xianju Pharmaceutical Co Ltd has underperformed ROG, delivering a return of -2% compared to the ROG's +22% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
002332
ROG
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Z
Intrinsic Value
10.73
CNY
Undervaluation 12%
ROG
Intrinsic Value
413.06
CHF
Undervaluation 11%
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
|
9.39
CNY
|
|||||
|
Roche Holding AG
SIX:ROG
|
367.9
CHF
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
002332, ROG
002332, ROG
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Roche Holding AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
002332, ROG
002332, ROG
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
|
|||||||||
|
|
Roche Holding AG
SIX:ROG
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Zhejiang Xianju Pharmaceutical Co Ltd
62.8%
ROG
73.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
Operating Margin
Zhejiang Xianju Pharmaceutical Co Ltd
13.4%
ROG
33.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
Net Margin
Zhejiang Xianju Pharmaceutical Co Ltd
7.6%
ROG
15.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
FCF Margin
Zhejiang Xianju Pharmaceutical Co Ltd
2.9%
ROG
21.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROE
Zhejiang Xianju Pharmaceutical Co Ltd
4.6%
ROG
32.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROA
Zhejiang Xianju Pharmaceutical Co Ltd
3.9%
ROG
9.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROIC
Zhejiang Xianju Pharmaceutical Co Ltd
6.8%
ROG
19.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROCE
Zhejiang Xianju Pharmaceutical Co Ltd
7.8%
ROG
30.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
Solvency Comparison
Z
Zhejiang Xianju Pharmaceutical C...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
002332, ROG
002332, ROG
Performance By Year
002332, ROG
002332, ROG
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 002332 to other stocks
LLY
Eli Lilly and Co
More expensive
vs Zhejiang Xianju Pharmaceutical Co Ltd
JNJ
Johnson & Johnson
More expensive
vs Zhejiang Xianju Pharmaceutical Co Ltd
NOVN
Novartis AG
More expensive
vs Zhejiang Xianju Pharmaceutical Co Ltd
AZN
AstraZeneca PLC
More expensive
vs Zhejiang Xianju Pharmaceutical Co Ltd
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
